Related by context. All words. (Click for frequent words.) 71 pancreatic adenocarcinoma 71 prostate cancer CaP 71 Adjuvant chemotherapy 70 breast carcinoma 70 colorectal carcinoma 70 HNSCC 70 prostate carcinoma 69 renal carcinoma 69 surgically resectable 69 urothelial cancer 69 renal cell carcinomas 69 nonmetastatic 69 seminomas 69 Squamous 68 GISTs 68 prostate cancer PCa 68 Radical prostatectomy 68 bladder cancers 68 nonmelanoma skin cancers 68 CIN3 68 malignant pleural mesothelioma 68 bronchogenic carcinoma 68 endometrial hyperplasia 68 basal cell carcinoma BCC 68 differentiated thyroid 68 lung carcinomas 68 Hurthle cell 68 lobular carcinoma 68 Anaplastic 67 HER2 overexpression 67 intestinal metaplasia 67 Papillary 67 histologic subtype 67 renal tumors 67 pT2 67 liver metastasis 67 papillary carcinoma 67 epithelial tumors 67 Carcinoid tumors 67 peritoneal cancer 67 metastatic renal cell carcinoma 67 hepatorenal syndrome 67 urothelial carcinoma 67 nonseminoma 67 basal cell cancers 67 nonsmall cell lung cancer 67 metastatic colorectal 67 operable breast cancer 67 HER2 positive cancers 67 Chronic lymphocytic leukemia 67 neoadjuvant therapy 67 gastric cancers 67 papillary renal cell carcinoma 67 T1a 67 T1c 67 serous ovarian cancer 67 squamous cell carcinoma SCC 67 testicular cancers 67 Leukemias 67 ductal cancer 67 neoplasias 66 Basal cell 66 epithelial ovarian cancer 66 grade gliomas 66 pT3 66 Squamous cell 66 node metastases 66 leiomyomas 66 ductal breast cancer 66 cytoreduction 66 MALT lymphoma 66 Glioblastoma Multiforme 66 urothelial bladder cancer 66 cutaneous melanoma 66 Rectal cancer 66 fallopian tube carcinoma 66 Gleevec resistant 66 histological subtype 66 IV NSCLC 66 metastatic neuroendocrine tumors 66 metastatic malignant melanoma 66 hepatocellular carcinomas 66 Gliomas 66 stage IIIB 66 LHRH receptor positive 66 Testicular cancer 66 skeletal metastases 66 paraganglioma 66 mycosis fungoides 66 mucinous 66 anaplastic 66 cisplatin resistant 66 pheochromocytoma 66 follicular lymphomas 66 Stage IIB 66 Myelosuppression 66 squamous cell lung cancer 66 prostate adenocarcinoma 66 nodal metastasis 66 superficial bladder cancer 66 recurrent glioblastoma multiforme 66 thyroid nodules 66 Malignant Melanoma 65 relapsed ovarian cancer 65 locoregional recurrence 65 medically inoperable 65 relapsed MM 65 breast carcinomas 65 choriocarcinoma 65 allogeneic HSCT 65 metastatic bladder 65 Hepatocellular Carcinoma HCC 65 colorectal cancer CRC 65 atypical hyperplasia 65 endometrial cancers 65 hormone refractory 65 NMIBC 65 colorectal adenoma 65 Soft Tissue Sarcoma 65 HGPIN 65 ADPKD 65 neuroendocrine cancers 65 sarcomatoid 65 CIN2 + 65 Paraplatin ® 65 metastatic lung cancer 65 candidemia 65 metastatic GIST 65 transarterial chemoembolization 65 myelofibrosis polycythemia vera 65 hematopoietic cancers 65 Surgical resection 65 Glioma 65 lung cancer NSCLC 65 advanced neoplasia 65 tumor histology 65 androgen deprivation 65 malignant growths 65 Acute myeloid leukemia 65 Anthracycline 65 paragangliomas 65 metastatic gastric 65 PCa 65 invasive ductal 65 resectable 65 underwent resection 65 Gastric cancer 65 Follicular lymphoma 65 lymphocytic 65 LHRH agonists 65 cutaneous squamous cell carcinoma 65 Metastatic breast cancer 65 K ras mutations 65 carcinoid tumors 65 lymphocytic leukemia 64 colorectal neoplasms 64 nonalcoholic steatohepatitis NASH 64 osteosarcomas 64 transplantation HCT 64 nasopharyngeal carcinoma 64 adenomatous polyps 64 stage IIIA 64 malignant lymphoma 64 Endometrial cancer 64 breast endometrial 64 grade cervical intraepithelial 64 grade serous ovarian 64 neoplasia 64 Chronic lymphocytic leukemia CLL 64 gastric adenocarcinoma 64 idiopathic myelofibrosis 64 prostate cancer CRPC 64 prostate TURP 64 pCR 64 ovarian carcinoma 64 hamartomas 64 pancreatic carcinoma 64 carcinoid 64 Chronic Prostatitis 64 leukemia AML 64 elevated LDH 64 Adenomas 64 cervical carcinoma 64 ovarian malignancy 64 malignant ascites 64 malignant prostate 64 carcinoid tumor 64 curable cancers 64 diabetes mellitus DM 64 endometrial carcinoma 64 precancerous cervical lesions 64 Metastatic 64 biliary tract cancer 64 recurrent ovarian cancer 64 distant metastasis 64 Glioblastoma Multiforme GBM 64 thymoma 64 Benign prostatic hyperplasia BPH 64 GnRH agonists 64 carcinoids 64 Sezary syndrome 64 peritoneal carcinomatosis 64 neoplasms 64 MGUS 64 Doxil ® 64 adjuvant radiation 64 astrocytoma 64 KRAS wild 64 gastrointestinal stromal tumors 64 Adjuvant therapy 64 B Cell Lymphoma 64 Medullary thyroid cancer 64 alkylating agent 64 Cystectomy 64 Chronic pancreatitis 64 clinically localized prostate 64 Waldenstrom macroglobulinemia 64 KRAS oncogene 64 advanced adenomas 64 cytoreductive surgery 64 androgen ablation 64 Follicular Lymphoma 64 malignant neoplasm 64 hematologic toxicity 63 prostate cancer HRPC 63 Nilotinib 63 adjuvant radiotherapy 63 smoldering myeloma 63 specific antigen PSA 63 nonproliferative 63 ovarian carcinomas 63 Radiofrequency ablation 63 Metastases 63 pituitary adenomas 63 pulmonary metastases 63 neoplasm 63 BRAF mutations 63 HIV HCV coinfected 63 Lymphomas 63 relapsing remitting MS RRMS 63 invasive lobular 63 invasive candidiasis 63 hypermethylated 63 lymphocytosis 63 Cutaneous T 63 metastatic renal 63 basal cell nevus syndrome 63 Acute lymphoblastic leukemia 63 bacterial prostatitis 63 histopathologic examination 63 ductal carcinomas 63 recurrent malignant glioma 63 bladder carcinoma 63 tumors GIST 63 oesophageal adenocarcinoma 63 prostate cancers 63 erlotinib Tarceva ® 63 cancerdefine 63 ASCUS 63 lymphomas leukemias 63 Cholangiocarcinoma 63 Pemetrexed 63 cystectomy 63 malignant lymphomas 63 EGFR mutation positive 63 testicular tumors 63 myeloid leukemia 63 precursor lesions 63 KRAS mutation 63 situ LCIS 63 metastatic ovarian cancer 63 preoperative chemotherapy 63 cervical lesions 63 mycophenolate mofetil 63 invasive carcinoma 63 HBeAg negative 63 Leydig cell 63 ovarian lung 63 prostate pancreatic 63 gastrointestinal stromal tumors GISTs 63 localized renal 63 castrate resistant 63 Ductal carcinoma 63 prostate carcinomas 63 lichen planus 63 orchitis 63 malignant ovarian 63 castrate resistant prostate cancer 63 Hypotension 63 chlamydial infection 63 malignant brain 63 BRCA deficient 63 Candida infection 63 hepatocellular carcinoma 63 leukoencephalopathy 63 polypoid 63 Toxicities 63 pancreatic lung 63 underwent surgical resection 63 Carcinoma 63 proctitis 63 neuroblastomas 63 PSADT 63 haematopoietic stem cell 63 leukemia CLL 63 urine cytology 63 chemotherapy cisplatin 63 leiomyoma 63 malignant cancerous 63 Uterine cancer 63 severe neutropenia 63 grade glioma 63 PCNSL 63 hepatoma 63 pheochromocytomas 63 invasive carcinomas 63 pelvic lymphadenectomy 63 nonmelanoma skin cancer 63 adenocarcinomas 63 subependymal giant cell 63 adenoma 63 anterior uveitis 63 metachronous 63 cancer mCRC 63 testicular germ cell 63 Glioblastoma multiforme 63 non squamous NSCLC 63 lymph node involvement 62 thrombocytopenic 62 CYT# potent vascular disrupting 62 trastuzumab Herceptin ® 62 Glioblastoma multiforme GBM 62 endometrioid 62 micrometastases 62 premalignant 62 orchiectomy 62 soft tissue sarcomas 62 aromatase inhibitors AIs 62 lobular cancer 62 complement inhibitor eculizumab 62 epithelial ovarian 62 myeloproliferative neoplasms 62 HER2 positive breast cancer 62 Neoadjuvant 62 locoregional 62 sentinel lymph node biopsy 62 neutrophil counts 62 imatinib Gleevec 62 urolithiasis 62 histologies 62 metastatic prostate cancer 62 Allogeneic 62 carotid plaques 62 gastric cardia 62 recurrent glioblastoma 62 colorectal liver metastases 62 recurrent glioma 62 recurrent ovarian 62 basal cell skin 62 stage IIIB IV 62 Epstein Barr virus EBV 62 vestibular schwannomas 62 leukocytosis 62 lymphadenectomy 62 hepatocellular cancer 62 acute leukemias 62 haematologic 62 kidney urologic 62 Synovial sarcoma 62 Atypical Hemolytic Uremic Syndrome 62 chemoresistant 62 cisplatin chemotherapy 62 Ribavirin causes 62 axillary lymph nodes 62 GBM tumors 62 SLNB 62 recurrent metastatic 62 gastric carcinoma 62 medullary thyroid cancer 62 immunosuppressive regimen 62 precancer 62 ovarian tumors 62 Myelodysplastic Syndrome MDS 62 gastrointestinal GI cancers 62 mutated K ras 62 PHPT 62 Vidaza ® 62 resistant hormone refractory 62 CMV disease 62 adriamycin 62 refractory ovarian cancer 62 adenomatous 62 SOD2 gene 62 cancerous enlargement 62 atrophic gastritis 62 allogeneic hematopoietic stem cell 62 cytopenias 62 CMV infections 62 MAGE A3 ASCI 62 infective endocarditis 62 LHRH agonist 62 CMV infection 62 postoperative chemotherapy 62 cell carcinomas 62 myeloablative 62 invasive ductal carcinoma 62 System IPSS 62 neuroendocrine carcinoma 62 cancerous polyps 62 Acute Myeloid Leukaemia AML 62 gefitinib Iressa 62 intravenous bisphosphonates 62 alveolar rhabdomyosarcoma 62 Microalbuminuria 62 lung adenocarcinoma 62 mRCC 62 glioblastomas 62 Prostatitis 62 allogeneic stem cell 62 incidentalomas 62 Polycythemia vera 62 serum urate levels 62 chemo radiotherapy 62 nonnucleoside reverse transcriptase inhibitors 62 invasive ductal breast cancer 62 metastatic kidney 62 metastatic malignant 62 leukemia ALL 62 ano genital warts 62 primary hyperparathyroidism 62 radioiodine therapy 62 B7 H3 62 demonstrated antitumor activity 62 Chronic Myelogenous Leukemia CML 62 papillary 62 radical nephrectomy 62 leukemia APL 62 biochemical recurrence 62 metastatic RCC 62 esophageal adenocarcinoma 62 Natalizumab 62 intravesical therapy 62 acute myelogenous leukemia AML 62 astrocytomas 62 chemoradiotherapy 62 acute myeloid 62 thyroid carcinoma 62 trabectedin 62 situ CIS 62 bowel cancers 62 vinca alkaloid 62 radiochemotherapy 62 mutated KRAS 62 PET CT colonography 62 surgical debulking 62 pancreatic cancers 62 lobular breast cancer 62 recurrent NSCLC 62 advanced metastatic prostate 62 metaplasia 62 Recurrences 62 Glioblastoma 62 endocrine tumors 61 neurologic complications 61 Graft Versus Host 61 KRAS mutations occur 61 unresectable tumors 61 pleural mesothelioma 61 Esophageal cancer 61 refractory NSCLC 61 urethritis 61 hyperplastic 61 Temsirolimus 61 Sentinel node biopsy 61 Adenocarcinoma 61 precancerous cervical 61 invasive lobular carcinoma 61 Thyroid nodules 61 histologically confirmed 61 NRTI resistance 61 oral squamous cell 61 precancerous condition 61 Glioblastomas 61 T2DM 61 Androgen deprivation therapy 61 epithelioid 61 perioperative morbidity 61 familial pancreatic cancer 61 metastatic prostate 61 CP CPPS 61 lymphoproliferative disorders 61 non squamous 61 abnormal cytology 61 receptor tyrosine kinase inhibitor 61 lymphomas 61 colorectal polyp 61 AA Amyloidosis 61 radiosensitivity 61 flutamide 61 gastrointestinal stromal tumors GIST 61 gastrointestinal stromal tumor 61 fibroadenomas 61 autologous transplants 61 Mitomycin C 61 neoadjuvant 61 transurethral resection 61 malignant pancreatic 61 lung resections 61 recurrent glioblastoma multiforme GBM 61 tigecycline 61 Erlotinib 61 completely resected 61 gastrointestinal stromal tumor GIST 61 chromosomal mutations 61 basiliximab 61 post transplant lymphoproliferative 61 estrogen receptor negative 61 malignant neoplasms 61 gonococcal infections 61 Folfox 61 LRP5 61 GIST tumors 61 leukaemias 61 cabazitaxel 61 LVNC 61 PSA nadir 61 CIN3 + 61 BRAF gene 61 acute aortic dissection 61 transplantation HSCT 61 GSTP1 61 Colon polyps 61 BRCA1 BRCA2 61 liver metastases 61 papillary thyroid carcinoma 61 Cardiotoxicity 61 oral Hycamtin 61 Relapsing remitting MS 61 hematological disorders 61 heavily pretreated 61 Tyrosine Kinase Inhibitors 61 ovarian breast 61 anthracycline taxane 61 hormone deprivation 61 PNET 61 mesotheliomas 61 transfusion syndrome 61 carcinomatosis 61 premalignant lesions 61 chronic myeloid 61 FOLFOX chemotherapy 61 neuroendocrine tumors 61 taxane therapy 61 trans retinoic acid ATRA 61 tumor xenograft models 61 pancreatic NET 61 malignant pheochromocytoma 61 Prostatic 61 solar keratosis 61 dasatinib Sprycel 61 #.#ng/ml 61 benign prostatic hypertrophy BPH 61 invasive bladder 61 distant metastases 61 undergone radical prostatectomy 61 biliary cancer 61 idarubicin 61 lung pancreatic 61 Trichomonas vaginalis 61 needle aspiration 61 spontaneously regress 61 Uterine fibroids 61 Metastatic Prostate Cancer 61 metastatic lymph nodes 61 melanoma lesions 61 pegylated liposomal doxorubicin 61 rituximab Rituxan 61 allogeneic bone marrow 61 bone metastasis 61 SSc 61 pancreatectomy 61 taxane chemotherapy 61 atypical ductal hyperplasia 61 acute lymphoblastic 61 Tumours 61 Lymphocytic 61 cervical lymph nodes 61 dysplastic nevi 61 mTOR inhibitors 61 Accelerated Partial Breast Irradiation 61 ductal adenocarcinoma 61 thalidomide Thalomid 61 pre cancerous lesion 61 varices 61 endocrine therapies 61 indolent lymphomas 61 chronic lymphocytic leukemia CLL 61 benign proliferative breast 61 antimetabolites 61 carcinoma HCC 61 NSCLC 61 peritumoral brain edema 61 immunocompetent 61 ertapenem 61 Chlamydia trachomatis infection 61 PTLD 61 nucleoside analogue 61 squamous carcinoma 61 malignant polyps 61 Hodgkin lymphoma HL 61 Benign breast 61 haematological 61 pancreatic neuroendocrine tumors 61 oligodendrogliomas 61 Naive Patients 61 antiandrogen 61 sCJD 61 Androgenetic Alopecia 61 myelomas 61 serum PSA 61 castration resistant 61 HER2 expression 61 Brain metastases 61 Inhibin B 61 undergoing radical prostatectomy 61 stage IIIb IV 61 common hematologic malignancy 61 cytogenetic responses 61 diagnostic biomarker 61 Renal cell carcinoma 61 Flu Cy 61 thrombocytosis 61 Hashimoto thyroiditis 61 Basal Cell 61 essential thrombocythemia 61 MYCN amplification 61 Endometrial 61 transarterial 61 PROSTVAC VF 60 non Hodgkin lymphomas 60 cholangiocarcinoma 60 androgen independent 60 TEAEs 60 TMP SMX 60 rectal cancers 60 chronic leukemias 60 gemcitabine Gemzar 60 indolent lymphoma 60 cranial irradiation 60 cell lymphoma ALCL 60 curative resection 60 coagulase negative staphylococci 60 hematological diseases 60 mycophenolate 60 Chronic HCV 60 GNAQ 60 Lymph node 60 metastatic renal cell 60 CIN2 60 neuroblastoma tumors 60 polyp recurrence 60 PCOD 60 Meningiomas 60 advanced metastatic renal 60 tamoxifen Nolvadex ® 60 PAOD 60 pelvic malignancies 60 leukemias lymphomas 60 ethambutol 60 advanced adenoma 60 1 diabetes T1D 60 complete cytogenetic response 60 colorectal polyps 60 pleomorphic 60 choroidal neovascularization 60 Relapsed Refractory 60 herpes zoster shingles 60 superficial basal cell carcinoma 60 FluCAM arm 60 Acute myelogenous leukemia 60 hepatic metastases 60 intracranial hemorrhage ICH 60 localized prostate cancer 60 neoplastic cells 60 myoma 60 hyperplastic polyps 60 premalignant lesion 60 hepatocellular carcinoma HCC 60 refractory anaplastic astrocytoma 60 microwave hyperthermia 60 alcoholic hepatitis 60 Glucocorticoids 60 Acute myeloid leukemia AML 60 NPM1 mutations 60 Diverticulosis 60 telomere lengths 60 BRCA mutation carriers 60 HER2 amplification 60 neutropenic patients 60 uterine tumors 60 Chronic Lymphocytic Leukemia 60 anthracycline containing 60 mutated KRAS gene 60 HER2 positive breast 60 Fludarabine 60 pulmonary metastasis 60 proliferative disorders 60 follicular lymphoma FL 60 Hormone Refractory Prostate Cancer 60 Malignant glioma 60 Irinotecan 60 Nymox NX 60 immunosuppressed patients 60 doublet chemotherapy 60 Basal cell carcinoma 60 Leucovorin 60 leiomyosarcoma 60 squamous 60 cyclophosphamide methotrexate 60 minimally symptomatic 60 colorectal adenocarcinoma 60 antiangiogenic therapy 60 familial ALS 60 squamous cell cancers 60 IV melanoma 60 alkylating agents 60 carotid stenosis 60 EGFR tyrosine kinase inhibitors 60 hemorrhagic cystitis 60 hormone receptor negative 60 eflornithine 60 imatinib Gleevec ® 60 colorectal cancers 60 ReA 60 systolic dysfunction 60 irinotecan chemotherapy 60 RET PTC rearrangements 60 anti androgen 60 adverse cytogenetics 60 IDH mutations 60 Helicobacter pylori infection 60 multimodality therapy 60 metastatic tumors 60 colon carcinoma 60 onset diabetes mellitus 60 autoimmune pancreatitis 60 thyroglobulin 60 benign polyps 60 rFVIIa 60 Malignant mesothelioma 60 thymectomy 60 Oesophageal cancer 60 localized prostate 60 taxane resistant 60 myeloproliferative disorders 60 prostate cancer mCRPC 60 pancreatic prostate 60 cisplatin gemcitabine 60 bleomycin 60 resected pancreatic cancer 60 pulmonary hypertension PH 60 VP# [004] 60 lobular carcinomas 60 metastatic lesions 60 pyrimethamine 60 bone marrow transplantations 60 Progressive Multifocal Leukoencephalopathy 60 pilocytic astrocytomas 60 lymphadenopathy 60 KRAS status 60 refractory prostate cancer 60 prednisone prednisolone 60 pathologic diagnosis 60 colorectal gastric 60 recurrent VTE 60 solar keratoses 60 neoplastic 60 cell carcinoma 60 colorectal lung 60 Idiopathic Pulmonary Fibrosis 60 metastatic castration resistant 60 Latent TB 60 adenocarcinoma 60 Cell Lymphoma 60 advanced medullary thyroid 60 nucleoside analogues 60 Fluorouracil 60 carcinoma 60 myelodysplastic syndrome MDS 60 radiotherapy RT 60 lymphoid tumors 60 antiandrogens 60 invasive aspergillosis 60 Carcinomas 60 Enzastaurin 60 malignancy 60 Bevacizumab Avastin 60 Asymptomatic 60 small lymphocytic lymphoma 60 Kaposi sarcoma 60 haematological toxicity 60 thromboembolic complications 60 situ DCIS 60 systemic fungal infections 60 prostate cancer AIPC 60 busulfan 60 chemoradiation therapy 60 proliferative diabetic retinopathy 60 Bladder cancer 60 Chronic sinusitis 60 salpingo oophorectomy 60 mg/m2 dose 60 Extensively drug 60 Venous thromboembolism 60 BRAF V#E 60 dysglycemia 60 GSTT1 60 Neoplasms 60 lactate dehydrogenase LDH 60 decompensated cirrhosis 60 genital herpes infections 60 colorectal carcinomas 60 colorectal adenomas 60 nondiabetic patients 60 urethral stricture 60 acute GvHD 60 medullary thyroid carcinoma 60 symptomatic BPH 60 SUVmax 60 overt hypothyroidism 60 perioperative complications 60 hormone refractory metastatic prostate 60 cytologically confirmed 60 Myelofibrosis 60 ovarian endometrial 60 radical prostatectomy RP 60 diffuse gastric 60 benign neoplasms 60 deletion 5q 60 prostate cancer metastases 60 Enlarged prostate 60 TNF blocker therapy 60 lung ovary 60 allogeneic hematopoietic cell 60 teratoma 60 nasopharyngeal cancer 60 cervical intraepithelial neoplasia 60 T1DM 60 BARACLUDE ® 60 amenorrhoea 60 Lymphoid 60 baseline LDH 60 dysplastic lesions 60 relapsed ALL 60 recurrent colorectal cancer 60 prolonged QT interval 60 CLL SLL 60 papillomas 60 HER2 negative 60 Kidney transplantation 60 etiologic agent 60 pulmonary dysfunction 60 Chronic Myeloid Leukemia 60 BEACOPP 60 cytotoxic therapies 60 erythema nodosum 60 Subgroup analysis 60 glioblastoma multiforme GBM 60 uveal melanoma 60 H. pylori eradication 60 Acute Myelogenous Leukemia AML 60 eribulin 60 ischemic lesions 60 Lung transplantation 60 adrenocortical cancer 60 acne vulgaris 60 systemic amyloidosis 60 Diabetic nephropathy 60 vinca alkaloids 59 Malignant Glioma 59 sentinel nodes 59 esophagogastric junction 59 histologic subtypes 59 corticosteroid therapy 59 imatinib resistance 59 sorafenib Nexavar 59 Riluzole 59 hamartoma 59 KRAS mutations 59 macroalbuminuria 59 RAS mutations 59 trans retinoic acid 59 diverticular bleeding 59 Non Alcoholic Steatohepatitis 59 mycophenolic acid 59 esophageal carcinoma 59 ANCA associated 59 CTAP# Capsules 59 breast pancreatic 59 invasive coronary angiography 59 acute promyelocytic leukemia 59 ER CHOP 59 SHBG levels 59 esophageal cancers 59 chronic periodontitis 59 BRCA2 mutation carriers 59 xenograft tumors 59 lung adenocarcinomas 59 de novo AML 59 surgically resected 59 chronic prostatitis 59 DCIS ductal carcinoma 59 Stomach cancer 59 liposomal amphotericin B 59 lobular 59 tuberous sclerosis TS 59 polycythemia vera PV 59 Advanced Melanoma 59 nonmelanoma 59 ovarian pancreatic 59 Pulmonary hypertension 59 Advanced Renal Cell 59 follicular thyroid cancer 59 pediatric acute lymphoblastic 59 Hormonal therapy 59 EGFR mutations 59 hypereosinophilic syndrome 59 Pneumocystis carinii pneumonia 59 sleeve lobectomy 59 Squamous cell carcinomas 59 hypovitaminosis D 59 neoplastic diseases 59 cytologic 59 hepatocellular carcinoma liver 59 abacavir Ziagen 59 MGd 59 CSF biomarkers 59 serum creatinine levels 59 lymph node metastasis 59 percutaneous drainage 59 cirrhosis liver failure 59 postoperative mortality 59 Vidaza azacitidine 59 treat benign prostatic 59 haematological malignancies 59 deep venous thromboses 59 Pancreatic neuroendocrine tumors 59 lupus nephritis 59 HER2 Positive Breast Cancer 59 YONDELIS 59 lymphoma subtypes 59 Epidermal Growth Factor Receptor 59 luteinizing hormone releasing 59 P. acnes 59 subclinical hyperthyroidism 59 uterine cervix 59 CaP 59 neoplasia PIN 59 6 mercaptopurine 59 troponin T 59 latent celiac disease 59 GABHS 59 intra arterial chemotherapy 59 Epstein Barr Virus EBV 59 fungoides 59 Estrogen Receptor 59 Cytarabine 59 Malignant melanoma 59 docetaxel chemotherapy 59 recurrent venous thromboembolism 59 percutaneous biopsy 59 Systemic lupus erythematosus 59 prognostic indicator 59 ductal 59 bile duct cancers 59 Legg Calvé Perthes disease 59 subclinical disease 59 refractory metastatic 59 TTR amyloidosis 59 CHOP chemotherapy 59 Invasive Breast Cancer 59 Platinol ® cisplatin 59 postoperative complication 59 antibody mediated rejection 59 DFMO 59 Staphylococcus aureus infections 59 thyrotoxicosis 59 genitourinary cancers 59 tumor recurrence 59 Decitabine 59 adjuvant trastuzumab 59 Epstein Barr Virus 59 wedge resection 59 Prognostic factors 59 cirrhotic 59 precancerous spots 59 synovial sarcoma 59 basal cell carcinomas 59 Neovascular Age Related Macular